^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
TPIV200
i
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Marker Therap, Mayo Clinic
Drug class:
Folate receptor 1 inhibitor, Folate receptor 2 inhibitor
Related drugs:
